Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer

NCT00431080 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

478

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Docetaxel
DRUG: Paclitaxel
DRUG: Epirubicin
DRUG: Cyclophosphamide
DRUG: 5-fluoruracil
DRUG: Granulocyte-colony stimulating growth factor

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]